Trial Profile
Assessment of Endothelial VAsomotricity after treatment by Nicotinic Acid in Patients presenting a recent Acute Coronary Syndrome.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 10 Jul 2012
Price :
$35
*
At a glance
- Drugs Niacin (Primary)
- Indications Acute coronary syndromes
- Focus Pharmacodynamics
- Acronyms EVAN-ACS
- 05 Nov 2010 New trial record.